Home GlaxoSmithKline Pharma loses patent claim on breast cancer drug Tykerb
 

Keywords :   


GlaxoSmithKline Pharma loses patent claim on breast cancer drug Tykerb

2013-08-02 16:15:06| Biotech - Topix.net

The Intellectual Property Appellate Board has revoked the patent granted to the British drug major Glaxosmithkline Pharma Ltd for its breast cancer drug - Tykerb.

Tags: drug claim cancer patent

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
28.11SCR
28.1146
28.11BOSS OD-2 TURBO Over Drive
28.11/ Pulling the Plug
28.11
28.1110
28.112.5 120
28.11MSV-R
More »